Prof Edith Perez spoke to ecancer at the BGICC 2020 conference in Cairo, Egypt about what to do in a situation where patients do not receive complete pathologic response after neoadjuvant therapy.

Prof Perez discusses some recent adjuvant drugs that could be applied, and a recent study from the Mayo Clinic.

She then touches upon how vaccines could work in this way for triple negative breast cancer, the data of which is not yet out.